buthionine sulfoximine and glutathione depletion - an overview The glutathione synthesis inhibitor buthionine

Persistence of Minimal Residual Disease Assessed by Multi-parameter Flow Cytometry (MFC) at 30 and 90 days After Achieving Complete Remission Predicts Outcome in Patients with Acute Myeloid Leukemia

No sugar, No soy, and gluten free

The acetylation-modulating capacity of butyrate positions it as a promising therapeutic candidate in treating cancer, inflammation, and neurological diseases (Table 1)

Nanoparticles can be used to encapsulate the viral antigen into the nanoparticle core (e.g., mRNA lipid nanoparticles), or they can present the antigen as protein on the surface of the nanoparticles (e.g., virus-like particles, protein nanoparticles)

E.Di BiaseM